Andra AP fonden acquired a new position in Metlife Inc (NYSE:MET) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 159,400 shares of the financial services provider’s stock, valued at approximately $6,786,000.

Other large investors have also recently made changes to their positions in the company. Dana Investment Advisors Inc. acquired a new stake in Metlife in the fourth quarter valued at approximately $450,000. Sigma Planning Corp grew its holdings in Metlife by 16.9% in the first quarter. Sigma Planning Corp now owns 15,922 shares of the financial services provider’s stock valued at $678,000 after purchasing an additional 2,297 shares during the period. Belpointe Asset Management LLC grew its holdings in Metlife by 169.9% in the fourth quarter. Belpointe Asset Management LLC now owns 14,593 shares of the financial services provider’s stock valued at $599,000 after purchasing an additional 9,187 shares during the period. MML Investors Services LLC grew its holdings in Metlife by 22.3% in the fourth quarter. MML Investors Services LLC now owns 69,961 shares of the financial services provider’s stock valued at $2,873,000 after purchasing an additional 12,779 shares during the period. Finally, Prudential Financial Inc. grew its holdings in Metlife by 13.6% in the fourth quarter. Prudential Financial Inc. now owns 5,202,203 shares of the financial services provider’s stock valued at $213,603,000 after purchasing an additional 620,879 shares during the period. Hedge funds and other institutional investors own 75.74% of the company’s stock.

A number of analysts have recently issued reports on MET shares. ValuEngine lowered Metlife from a “hold” rating to a “sell” rating in a research note on Wednesday, March 20th. UBS Group lifted their price target on Metlife from $45.00 to $48.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 9th. Sandler O’Neill lowered Metlife from a “buy” rating to a “hold” rating and set a $50.00 price target on the stock. in a research note on Tuesday, March 19th. Wells Fargo & Co reaffirmed a “buy” rating and issued a $55.00 price target on shares of Metlife in a research note on Wednesday, June 5th. Finally, Barclays lifted their price target on Metlife from $52.00 to $55.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 22nd. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $50.59.

NYSE MET opened at $48.42 on Thursday. The firm has a market cap of $46.11 billion, a price-to-earnings ratio of 8.98, a P/E/G ratio of 1.02 and a beta of 1.11. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.24. Metlife Inc has a fifty-two week low of $37.76 and a fifty-two week high of $50.40.

Metlife (NYSE:MET) last released its quarterly earnings data on Wednesday, May 1st. The financial services provider reported $1.48 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.30 by $0.18. The company had revenue of $15.45 billion for the quarter, compared to analyst estimates of $15.95 billion. Metlife had a return on equity of 10.20% and a net margin of 7.56%. The firm’s revenue for the quarter was up 2.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.36 earnings per share. Equities analysts anticipate that Metlife Inc will post 5.61 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 13th. Shareholders of record on Tuesday, May 7th will be paid a dividend of $0.44 per share. The ex-dividend date of this dividend is Monday, May 6th. This represents a $1.76 dividend on an annualized basis and a yield of 3.63%. This is a positive change from Metlife’s previous quarterly dividend of $0.42. Metlife’s payout ratio is 32.65%.

TRADEMARK VIOLATION WARNING: This piece was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2019/06/13/andra-ap-fonden-acquires-shares-of-159400-metlife-inc-nysemet.html.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Recommended Story: Why are percentage gainers important?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.